These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2073317)

  • 41. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
    Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
    Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species.
    Zehr KJ; Herskowitz A; Lee PC; Kumar P; Gillinov AM; Baumgartner WA
    Transplantation; 1994 Mar; 57(6):900-6. PubMed ID: 8154039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A perspective on xenograft rejection and accommodation.
    Platt JL
    Immunol Rev; 1994 Oct; 141():127-49. PubMed ID: 7868152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection.
    Dalmasso AP; Vercellotti GM; Platt JL; Bach FH
    Transplantation; 1991 Sep; 52(3):530-3. PubMed ID: 1716798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basement membrane proteoglycans are of epithelial origin in rodent skin.
    Yamane Y; Yaoita H; Couchman JR
    J Invest Dermatol; 1996 Mar; 106(3):531-7. PubMed ID: 8648189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets.
    Fryer JP; Leventhal JR; Dalmasso AP; Chen S; Simone PA; Goswitz JJ; Reinsmoen NL; Matas AJ
    Transplantation; 1995 Jan; 59(2):171-6. PubMed ID: 7839436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent strategies to overcome the hyperacute rejection in pig to human xenotransplantation.
    Igaz P
    Yale J Biol Med; 2001; 74(5):329-40. PubMed ID: 11769339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
    Gambiez L; Salame E; Chereau C; Calmus Y; Cardoso J; Ayani E; Houssin D; Weill B
    Transplantation; 1992 Oct; 54(4):577-83. PubMed ID: 1412747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
    Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
    Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The fourth barrier.
    Schraa EO; Marquet RL; IJzermans JN
    Curr Med Res Opin; 1999; 15(4):327-38. PubMed ID: 10640267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heparan sulphate proteoglycan and retinal microinfarcts in diabetes mellitus.
    Roy MS; Rick ME
    Diabetologia; 1989 Oct; 32(10):766. PubMed ID: 2531690
    [No Abstract]   [Full Text] [Related]  

  • 52. Prolongation of discordant renal xenograft survival by depletion of complement. Comparative effects of systemically administered cobra venom factor and soluble complement receptor type 1 in a guinea-pig to rat model.
    Chrupcala M; Pomer S; Staehler G; Waldherr R; Kirschfink C
    Transpl Int; 1994; 7 Suppl 1():S650-3. PubMed ID: 11271331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
    Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
    Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed xenograft rejection.
    Hancock WW
    World J Surg; 1997; 21(9):917-23. PubMed ID: 9361505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperacute lung rejection in the pig-to-human model 4: evidence for complement and antibody independent mechanisms.
    Pfeiffer S; Zorn GL; Blair KS; Farley SM; Wu G; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Transplantation; 2005 Mar; 79(6):662-71. PubMed ID: 15785372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Key role of the alternate complement pathway in hyperacute rejection of rat hearts transplanted into fetal sheep.
    Rajasinghe HA; Reddy VM; Hancock WW; Sayegh MH; Hanley FL
    Transplantation; 1996 Aug; 62(3):407-11. PubMed ID: 8779691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts.
    Rose AG; Cooper DK; Human PA; Reichenspurner H; Reichart B
    J Heart Lung Transplant; 1991; 10(2):223-34. PubMed ID: 2031919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discordant heart xenografts in the rat. Additional effect of plasma exchange and cyclosporine, cyclophosphamide, or splenectomy in delaying hyperacute rejection.
    Van de Stadt J; Vendeville B; Weill B; Crougneau S; Michel A; Filipponi F; Icard P; Renoux M; Louvel A; Houssin D
    Transplantation; 1988 Mar; 45(3):514-8. PubMed ID: 3279572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of complement in xenotransplantation.
    Mollnes TE; Fiane AE
    Allergy; 2002; 57 Suppl 72():75-8. PubMed ID: 12144560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.